vax2012q
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT02015494)
Timeline
Indications
Studied for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vax2012q
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02434276 | Phase 2 | May 1, 2015 | Accelovance, Department of Health and Human Services, VaxInnate Corporation |
| NCT02247362 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2014 | VaxInnate Corporation |
| NCT02015494 | Phase 1 | Mar 1, 2014 | VaxInnate Corporation |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VaxInnate Corporation | For profit | 3 | 3 | 2 | 2014 |
| Accelovance | For profit | 1 | 0 | 1 | 2015 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1